Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 50 /hr
Hire Dr. Wen Chean L.
Australia
USD 50 /hr

Medical Writer/ Life Sciences and Healthcare Consultant, 10+ years research experience in Immunology and Oncology

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Technical Writing, General Proofreading & Editing
Research Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection
Consulting Healthcare Consulting, Scientific and Technical Consulting
Work Experience

Associate Management Consultant

VMLY&R HEALTH Medical Consulting

April 2021 - March 2023

Autolus (United Kingdom)

March 2016 - March 2021

University of Southampton

May 2015 - February 2016

GlaxoSmithKline Research and Development

August 2009 - July 2010

Education

PhD in Infection, Inflammation and Immunity

University of Southampton

October 2011 - September 2015

BSc (Hons) Pharmacology with Industrial Experience

University of Manchester

October 2007 - June 2011

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Wen Chean Lim, Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, et al. (2024). Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies . Nature Communications.
Wen Chean Lim, Julia Taylor, Anna Bulek, Isaac Gannon, Mathew Robson, Evangelia Kokalaki, Thomas Grothier, Callum McKenzie, Mohamed El-Kholy, Maria Stavrou, et al.(2023). Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2 . Frontiers in Immunology. 14. Frontiers Media {SA}
Lee L, Lim WC, Galas-Filipowicz D, Fung K, Taylor J, Patel D, Akbar Z, Alvarez Mediavilla E, Wawrzyniecka P, Shome D, et al.(2023). Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy . Journal for immunotherapy of cancer.
(2017). Microwave therapy for cutaneous human papilloma virus infection . European journal of dermatology : EJD.